This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Alan Stokes: Innovator in Vaccine Technology
Introduction
Alan Stokes is a prominent inventor based in Rockville, MD (US). He has made significant contributions to the field of vaccine technology, particularly in the development of innovative constructs for preventing and treating diseases.
Latest Patents
Stokes holds a patent for "Lyssavirus antigen constructs." This patent focuses on nucleic acid-based vaccine constructs that encode Lyssaviral antigens. These constructs are designed to provide potent and long-lasting immunity against diseases caused by Lyssavirus.
Career Highlights
Alan Stokes is associated with GlaxoSmithKline Biologicals SA, where he has been instrumental in advancing vaccine research and development. His work has contributed to the understanding and application of self-amplifying RNA molecules in vaccine technology.
Collaborations
Some of his notable coworkers include Marcelo Samsa and Padma Malyala. Their collaborative efforts have further enhanced the research and development initiatives within their organization.
Conclusion
Alan Stokes is a key figure in the field of vaccine innovation, with a focus on developing effective solutions for disease prevention. His contributions continue to impact the scientific community and public health positively.